Activation of nuclear factor κB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: A brake to apoptosis in HeLa human carcinoma cells

Cancer Research

Volumn 61, Issue 21, 2001, Pages 7785-7791

  Bottero, Virginie ^a   Busuttil, Valère ^a   Loubat, Agnès ^a   Magné, Nicolas ^b,c   Milano, Gérard ^b,c   Peyron, Jean François ^b,c  

^a INSERM   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; GENE ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CAMPTOTHECIN; CELL SURVIVAL; CYCLOHEXIMIDE; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; DOXORUBICIN; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION; HELA CELLS; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 0035502956     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Taxol stabilizes microtubules in mouse fibroblast cells
2. Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
3. Fluorouracil biochemistrypharmacology
4. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin
5. Activators and target genes of Rel/NFκB transcription factors
6. NF-κB and Rel proteins evolutionarily conserved mediators of immune responses
7. NF-κB to the rescue
8. Aberrant rel/nfkb genes and activity in human cancer
9. TNF-α and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
10. Impaired regulation regulation of nuclear factor-κB results in apoptosis induced by γ radiation
11. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
12. Phosphorylation meets ubiquitination: The control of NF-κB activity
13. UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of an extracellular factor that induces HIV-1 transcription in nonirradiated cells
14. Ionizing radiation induces expression and binding activity of the nuclear factor κB
15. DNA topoisomerases
16. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
17. Mechanism of action of eukaryotic DNA topoisomerase II and drugs targeted to the enzyme
18. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives
19. IKK-1 and IKK-2: Cytokine-activated IκB Kinases essential for NF-κB activation
20. Complementation cloning of NEMO a component of the IκB kinase complex essential for NF-κB activation
21. Molecular Cloning. A Laboratory Manual
22. A detergen-trypsin method for the preparation of nuclei for flow cytometric DNA analysis
23. NF-κB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events
24. Topoisomerase II is required for mitoxantrone to signal nuclear factor KB activation in HL60 cells
25. ATM: A mediator of multiple responses to genotoxic stress
26. Ataxia-telangiectasia a multifaceted genetic disorder associated with defective signal transduction
27. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB
28. ATM is required for IKK activation in response to DNA double strand breaks
29. The ATM protein is required for sustained activation of NF-κB following DNA damage
30. The DNA-dependent protein kinase participates in the activation of NF-κB following DNA damage
31. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
32. Control of apoptosis by Rel/NF-κB transcription factors
33. Suppression of TNF-α-induced apoptosis by NF-κB
34. Nuclear factor-κB, cancer, and apoptosis
35. Role of NF-κB in p53-mediated programmed cell death
36. Role of NF-κB and 26S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human non-small cell lung carcinoma
37. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control
38. NF-κB antiapoptosis induction of TRAF1 and TRAF2 ans c-1AP1 and c-1AP2 to suppress caspase-8 activation
39. The pro-survival Bcl-2 homolog Bf1-1/A1 is a direct transcriptional target of that blocks TNFα-induced apoptosis
40. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
41. The c-1AP-1 and c-1AP-2 proteins are direct inhibitors of specific caspases
42. BCL-2 family members and the mitochondria in apoptosis